Medical News

RSS

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.

19 Mar 2010

FOCUS 7 forum helps individuals meet, participate and learn how to resolve specific issues

Are you facing an issue that's having an effect on your life? Do you wish you had a secure environment where you could share openly and get real-life solutions you can start applying immediately? Enter FOCUS 7, a new forum in metro Detroit where individuals can meet, participate and learn how to resolve specific issues with the help of an expert on that topic.

19 Mar 2010

GenMark Diagnostics files registration statement with Securities and Exchange Commission

GenMark Diagnostics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. GenMark is a Delaware corporation and, in connection with the offering, will become the parent holding company of Osmetech, plc.

19 Mar 2010

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.

19 Mar 2010

A.P. Pharma's NDA for APF530 in prevention of CINV: FDA issues Complete Response Letter

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for APF530 in the prevention of both acute and delayed onset chemotherapy-induced nausea and vomiting.

19 Mar 2010

Research group unveils new computational strategy for GWAS

In the ongoing quest to identify the genetic factors involved in disease, scientists have increasingly turned to genome-wide association studies, or GWAS, which enable the scanning of up to a million genetic markers in thousands of individuals.

19 Mar 2010

First Edition: March 19, 2010

The headlines reflect yesterday's flurry of activity as House Democratic Leaders unveiled their $940 billion health-care compromise bill and steamed toward a Sunday vote. All the while, Republican leaders plotted was to stall this progress and nullify the measure.

19 Mar 2010

Study reveals higher-than-normal blood levels of fructose in pancreatic cancer patients

Patients with pancreatic cancer have higher-than-normal blood levels of the refined sugar fructose, according to a recent study in the journal Pancreas, official journal of the American Pancreatic Association and the Japan Pancreas Society. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

19 Mar 2010

Global initiative for reducing time taken to introduce new combination TB treatments

Ahead of World TB Day, US Food and Drug Administration Commissioner Margaret Hamburg helped public and private sector partners launch a new collaboration to significantly accelerate the development of combination treatments for tuberculosis — and replace an almost 50-year-old drug regimen. Created by the Global Alliance for TB Drug Development, the Critical Path Institute, and the Bill & Melinda Gates Foundation, the initiative could potentially reduce the time it takes to introduce new combination TB treatments from as much as a quarter century to as few as six years.

19 Mar 2010

Hercules Technology Growth Capital commits over $52.0M in structured debt financing

Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed over $52.0 million in structured debt financing to new and existing portfolio companies.

19 Mar 2010

FDA restricts the sale, distribution and use of cigarettes and smokeless tobacco

A rule issued today by the Food and Drug Administration underscores the historical progress made towards fighting the nation's number one cause of preventable death: tobacco-related disease.

19 Mar 2010

First Lady and HHS Secretary to announce new grants for supporting public health efforts

On Friday, First Lady Michelle Obama and U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius will be joined by several high-ranking HHS officials to announce the release of new grants for communities to support public health efforts in preventing obesity and tobacco use while improving nutrition and increasing physical activity among the American people.

19 Mar 2010

RAND study: Common insurance plans may not achieve intended savings

Increasingly common insurance plans that encourage patients to receive care from physicians who keep medical costs lower are based on unreliable estimates of doctor performance and may not achieve the intended savings, according to a new RAND Corporation study.

19 Mar 2010

Six basic human emotions universally recognized, other positive emotions culturally specific

Humans use a wide range of different cues, both verbal and non-verbal, to share important information and particularly to warn others of danger. A team from University College London's psychology department studied a range of non-verbal emotional vocalizations, such as screams and laughs, in two very different cultural groups.

19 Mar 2010

Bactericidal antibiotic with activity against MRSA for treatment of cSSSIs would earn 25% patient share: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a therapy's effect on overall clinical success is the attribute that most influences surveyed infectious disease specialists' prescribing decisions in the treatment of complicated skin and skin structure infections (cSSSIs).

19 Mar 2010

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

AMAG Pharmaceuticals, Inc. today announced that one abstract has been accepted for presentation at the National Kidney Foundation 2010 Spring Clinical Meeting being held April 13-17, 2010 in Orlando, FL.

19 Mar 2010

New research project studies interactions between police and people with mental illness

One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.

19 Mar 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps). A second study examined endoscopist experience using TER and its impact on polyp detection rates, concluding that polyp detection rates improved significantly with TER.

19 Mar 2010

InvestorSoup.com announces investment report featuring Somaxon Pharmaceuticals

InvestorSoup.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

19 Mar 2010

Providence receives U.S. patent for CPMMS

Providence today announces the receipt of a United States Patent for the Comprehensive Particulate Matter Measurement System (CPMMS) and the Methodology for its Use. Yousheng Zeng, PhD, PE, a principal of Providence, is the inventor of this system. Dr. Zeng explains, "Unlike current methods of monitoring air-borne particulate matter (PM), the CPMMS monitors the portion of PM that can reach and deposit in a human respiratory system."

19 Mar 2010

Medical News

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

FOCUS 7 forum helps individuals meet, participate and learn how to resolve specific issues

GenMark Diagnostics files registration statement with Securities and Exchange Commission

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

A.P. Pharma's NDA for APF530 in prevention of CINV: FDA issues Complete Response Letter

Research group unveils new computational strategy for GWAS

First Edition: March 19, 2010

Study reveals higher-than-normal blood levels of fructose in pancreatic cancer patients

Global initiative for reducing time taken to introduce new combination TB treatments

Hercules Technology Growth Capital commits over $52.0M in structured debt financing

FDA restricts the sale, distribution and use of cigarettes and smokeless tobacco

First Lady and HHS Secretary to announce new grants for supporting public health efforts

RAND study: Common insurance plans may not achieve intended savings

Six basic human emotions universally recognized, other positive emotions culturally specific

Bactericidal antibiotic with activity against MRSA for treatment of cSSSIs would earn 25% patient share: Report

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

New research project studies interactions between police and people with mental illness

Studies reveal increased polyp detection rates with TER during colonoscopy

InvestorSoup.com announces investment report featuring Somaxon Pharmaceuticals

Providence receives U.S. patent for CPMMS

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News